Archive.fm

Idaho Matters

Idaho Matters Doctors Roundtable: July 20, 2022

The Novavax vaccine and why its considered more traditional, as well as nasal vaccines and when we can expect to see them.

Broadcast on:
20 Jul 2022
Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial.
Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial.(John Moore / Getty Images)

For people who have been waiting for a more traditional COVID-19 vaccine, health experts say that Novavax vaccine may be for you.

Late last week, regulators authorized the nation's first so-called protein vaccine and this week the CDC gave it a thumbs up. Joining Idaho Matters to talk more about this, plus other COVID-19 issues is Dr. David Pate, former CEO of St. Luke's Health System and a current member of the Idaho Coronavirus Task Force.